PI3 - peptidase inhibitor 3 Gene

Also Known as ESI; WAP3; SKALP; WFDC14; cementoin

Species: Homo sapiens

Gene Type: protein coding

Gene ID: 5266

About PI3

Cytogenetic location: 20q13.12 Genomic coordinates (GRCh38): 20:45,174,902-45,176,544 (from NCBI)

This gene has 1 transcript (splice variant), 80 orthologues and 9 paralogues. Biased expression in esophagus (RPKM 578.7), colon (RPKM 50.5) and 1 other tissue.

Summary

This gene encodes an elastase-specific inhibitor that functions as an antimicrobial peptide against Gram-positive and Gram-negative bacteria, and Fungal pathogens. The protein contains a WAP-type four-disulfide core (WFDC) domain, and is thus a member of the WFDC domain family. Most WFDC gene members are localized to chromosome 20q12-q13 in two clusters: centromeric and telomeric. This gene belongs to the centromeric cluster. Expression of this gene is upgulated by Bacterial lipopolysaccharides and cytokines. [provided by RefSeq, Oct 2014]

PI3 Products (1)

mRNA	Protein	Name
NM_002638.4	NP_002629.1	elafin preproprotein

Gene Ontology

Molecular Function
Biological Process
Cellular Component

Molecular Function GO Annotation	Evidence	References	Source
enables structural constituent of skin epidermis	IDA IDA: Inferred from direct assay	7543090	GOA

Biological Process GO Annotation	Evidence	References	Source
involved in peptide cross-linking	IDA IDA: Inferred from direct assay	7543090	GOA

Cellular Component GO Annotation	Evidence	References	Source
located in cornified envelope	IDA IDA: Inferred from direct assay	7543090	GOA

EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

PI3 Protein Structure

Cementoin

WAP

0
100
117 a.a.

Protein Preferred Names	Protein Names
elafin	PI-3

Recombinant PI3 Proteins

Cat. No.	Product Name	Accession	Purity
HY-P70316	Elafin/Trappin-2 Protein, Human (HEK293, His)	P19957 (A23-Q117)	≥ 95%, as determined by reducing SDS-PAGE.

Related Diseases

Diseases	Alias
Pustular Psoriasis
Farmer'S Lung	Farmer Lung Farmers Lung Farmer'S Lung Disease Farmers' Lung Farmers' Lung Disease Mouldy Hay Disease Moldy Hay Disorder Fibrosis Of Lung With Farmers' Lung Harvesters' Hypersensitivity Pneumonitis Moldy Hay Pneumoconiosis Haymakers' Hypersensitivity Pneumonitis Threshers' Lung Harvester Lung Haymaker Lung
Extrinsic Allergic Alveolitis	Hypersensitivity Pneumonitis Alveolitis, Extrinsic Allergic Alveolitis Allergic Interstitial Pneumonitis Allergic Pneumonitis Extrinsic Allergic Pneumonia Hypersensitivity Pneumonitis Hp Pneumonitis Hypersensitivity Allergic Alveolitis Extrinsic Allergic Alveolitis Nos Airway Obstruction With Allergic Alveolitis Unspecified Allergic Alveolitis And Pneumonitis Extrinsic Allergic Bronchiolo-Alveolitis Hypersensitivity Pneumonia Hypersensitivity Pneumonitis Nos Obstructive Lung Disease With Allergic Alveolitis Obstructive Lung Disorder With Hypersensitivity Pneumonitis Obstructive Lung Disorder With Allergic Alveolitis Obstructive Lung Disease With Hypersensitivity Pneumonitis
Erysipelas
Adult Respiratory Distress Syndrome	Acute Respiratory Distress Syndrome Ards Non-Cardiogenic Pulmonary Edema Acute Lung Injury Respiratory Distress Syndrome, Adult Shock Lung Acute Respiratory Distress Respiratory Distress Syndrome Adult Rds Ali Increased-Permeability Pulmonary Edema Stiff Lung Respiratory Distress Syndrome Adult
Impetigo
Netherton Syndrome	NETH Ns Netherton Disease Comel-Netherton Syndrome Erythroderma, Ichthyosiform, With Hypotrichosis And Hyper-Ige Bamboo Hair Syndrome Ichthyosis Linearis Circumflexa Ichthyosiform Erythroderma With Hypotrichosis And Hyper-Ige Ilc Nts N Syndrome
Allergic Contact Dermatitis	Dermatitis, Allergic Contact Contact Dermatitis, Allergic Dermatitis Allergic Contact Allergic Contact Eczema Acd - [Allergic Contact Dermatitis] Allergic Contact Dermatitis, Unspecified Cause Allergic Dermatitis Allergic Eczema Allergy Dermatitis Allergy Eczema Allergic Contact Eczema Due To Clothing Or Footwear Perfume Allergic Contact Dermatitis Allergic Contact Dermatitis Due To Cosmetics Allergic Contact Eczema Due To Cosmetics Or Fragrances Allergic Contact Eczema Due To Dental Materials Allergic Contact Eczema Due To Food Flavours Or Additives Allergic Contact Eczema Due To Hairdressing Products Allergic Contact Eczema Due To Metals Or Metal Salts Allergic Contact Eczema Due To Proteins Allergic Contact Eczema Due To Plastics Or Resin Systems Allergic Contact Eczema Due To Preservatives Or Biocides Allergic Contact Eczema Due To Rubber Chemicals Rubber Dermatitis Allergic Contact Eczema Due To Systemic Medicaments Allergic Contact Eczema Due To Topical Medicaments Allergic Contact Dermatitis Due To Drugs In Contact With Skin
Lung Disease	Lung Diseases Disorder Of Lung Abnormality Of The Lung
Psoriasis
Corneal Abscess
Double Pterygium
Pasteurellosis	Pasteurella Infection Pasteurella Infections Pasteurella Infectious Disease Shipping Fever Transport Fever
Skin Disease	Skin Diseases Genodermatosis Abnormality Of The Skin Skin Diseases, Genetic Skin And Subcutaneous Tissue Disease Dermatologic Disorders
Cystic Fibrosis	Mucoviscidosis CF Pseudomonas Aeruginosa, Susceptibility To Chronic Infection By, In Cystic Fibrosis Pseudomonas Aeruginosa Chronic Infection By, In Cystic Fibrosis Cystic Fibrosis Lung Disease, Modifier Of Cystic Fibrosis Of Pancreas Fibrocystic Disease Of Pancreas Cf - [Cystic Fibrosis] Cystic Fibrosis Nos Fibrocystic Disease Fibrocystic Disease Of The Pancreas Mucoviscidosis Of Pancreas Nonproliferative Fibrocystic Disease Pancreatic Cystic Fibrosis
Familiar Ovarian Carcinoma
Bacterial Infectious Disease	Bacterial Infections Bacterial Infection Nos Disease Caused By Bacteria Bacterial Disease Or Disorder
Type 1 Diabetes Mellitus 8	Diabetes Mellitus, Insulin-Dependent, 8 Iddm8 Insulin-Dependent Diabetes Mellitus 8 T1D8 Insulin-Dependent Diabetes Mellitus-8
Preterm Premature Rupture Of The Membranes	Preterm Premature Rupture Of Membranes PPROM Preterm Premature Rupture Of The Membranes, Susceptibility To Pprom - [Preterm Premature Rupture Of Membranes] Preterm Rupture Of Membranes
Pulmonary Disease, Chronic Obstructive	Chronic Obstructive Pulmonary Disease COPD Pulmonary Disease, Chronic Obstructive, Severe Early-Onset Chronic Obstructive Lung Disease Chronic Obstructive Airway Disease Pulmonary Disease, Chronic Obstructive, Susceptibility To Cold Severe Early-Onset Chronic Obstructive Pulmonary Disease Pulmonary Disease Chronic Obstructive Pulmonary Disease, Obstructive, Chronic, Susceptibility To Chronic Obstructive Pulmonary Disease Of Horses Common Cold Upper Respiratory Infections Copd - [Chronic Obstructive Pulmonary Disease] Coad - [Chronic Obstructive Airways Disease] Cold - [Chronic Obstructive Lung Disease] Chronic Airway Disease Nos Chronic Airways Limitation, Unspecified Chronic Obstructed Airway, Unspecified Chronic Obstructive Airway Disease, Unspecified Chronic Obstructive Airway, Unspecified Obstructive Lung Disease Nos Chronic Obstructive Lung Disease Nos Chronic Obstructive Lung Nos Obstructive Pulmonary Disease Nos Exacerbation Copd Nos Acute Exacerbation Copd
Parotid Gland Adenoid Cystic Carcinoma	Adenoid Cystic Carcinoma Of Parotid Gland
Joubert Syndrome 7	JBTS7 Cerebello-Oculo-Renal Syndrome 3 Cors3 Joubert Syndrome, Type 7
Inflammatory Bowel Disease	Inflammatory Bowel Diseases Bowel Disease, Inflammatory
Basal Cell Carcinoma	Basal Cell Cancer Basal Cell Neoplasm Basal Cell Carcinoma Of Skin Malignant Basal Cell Tumor Basal Cell Tumor Epithelioma Basal Cell Malignant Basal Cell Neoplasm Rodent Ulcer Carcinoma Basal Cell Neoplasms, Basal Cell Basal Cell Carcinomas Experimental Organism Basal Cell Carcinoma Nodulo-Ulcerative Basal Cell Carcinoma Basalioma Basal Cell Epithelioma Of Skin Bcc - [Basal Cell Carcinoma] Of Skin Rodent Ulcer Of Skin Rodent Ulcer Of Unspecified Site Basal Cell Epithelioma Of Unspecified Site

Diseases	Alias
Waldenstroem'S Macroglobulinemia	Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma Waldenstroem'S Macroglobulinemia Waldenstroem'S Macroglobulinemia Macroglobulinemia Of Waldenstrom Lymphoplasmacytic Lymphoma With Igm Gammopathy Lymphoplasmacytic Lymphoma

Related Agents

Approval
Clinical Phase
Pre-clinical Phase

Approval

Bioactive Molecules (61)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-10201	Sorafenib		99.85%	Yes
HY-18085	Quercetin		99.80%	Yes
HY-15244	Alpelisib		99.95%	Yes
HY-101562	Inavolisib		99.96%	Unkown
HY-B0633A	Hyaluronic acid	Activator	/	Yes
HY-13026	Idelalisib		99.94%	Yes
HY-15346	Copanlisib		99.35%	Unkown
HY-B0633	Hyaluronic acid sodium	Activator	98.0%	Unkown
HY-N0717	L-Valine		99.89%	Unkown
HY-17508	Clarithromycin	Inhibitor	99.90%	Yes
HY-10201A	Sorafenib tosylate		99.98%	Yes
HY-15346A	Copanlisib dihydrochloride		99.55%	Yes
HY-B0965	Thioridazine hydrochloride		99.96%	Unkown
HY-13685	Miltefosine	Inhibitor	99.92%	Yes
HY-10201S	Sorafenib-d3		99.57%	Unkown
HY-14151	Prucalopride		99.93%	Yes
HY-B0648	Medroxyprogesterone	Agonist	98.82%	Unkown
HY-18085R	Quercetin (Standard)		99.64%	Unkown
HY-14153A	Tegaserod maleate		99.90%	Unkown
HY-12279	Umbralisib	Inhibitor	98.94%	Yes
HY-B1203	Fludrocortisone		98.99%	Yes
HY-B0766	Bicyclol		99.91%	Unkown
HY-N0146	Quercetin dihydrate		≥97.0%	Yes
HY-14153	Tegaserod		99.71%	Unkown
HY-B0725	Doxepin Hydrochloride		99.64%	Yes
HY-N0717R	L-Valine (Standard)		99.89%	Unkown
HY-12694	Prucalopride succinate		99.94%	Yes
HY-17635	Leniolisib	Inhibitor	99.38%	Yes
HY-B0965A	Thioridazine		99.50%	Unkown
HY-15856B	Flupentixol dihydrochloride		99.73%	Yes
HY-W008923	Doxycycline monohydrate		98.95%	Unkown
HY-B0093	Benazepril		99.85%	Yes
HY-B0319	Tioconazole	Inhibitor	99.86%	Unkown
HY-10201R	Sorafenib (Standard)		99.71%	Unkown
HY-B1234	Octinoxate		99.84%	Unkown
HY-90003	Tianeptine		99.84%	Unkown
HY-N0565AR	Doxycycline (hydrochloride) (Standard)		99.97%	Unkown
HY-15244A	Alpelisib hydrochloride		99.55%	Yes
HY-17508R	Clarithromycin (Standard)	Inhibitor	99.93%	Unkown
HY-N0565BR	Doxycycline hyclate (Standard)		95.23%	Unkown
HY-90003A	Tianeptine sodium salt		99.90%	Unkown
HY-B0093A	Benazepril hydrochloride	Inhibitor	99.96%	Yes
HY-17635A	Leniolisib phosphate	Inhibitor	98.88%	Yes
HY-N0565R	Doxycycline (Standard)		97.16%	Unkown
HY-B0725A	Doxepin		99.66%	Yes
HY-B1550	Benzoin	Inhibitor	99.95%	Unkown
HY-15244R	Alpelisib (Standard)		99.86%	Unkown
HY-12279C	Umbralisib hydrochloride	Inhibitor	99.04%	Yes
HY-N0565C	Doxycycline calcium		/	Unkown
HY-B0725R	Doxepin Hydrochloride (Standard)		99.78%	Unkown
HY-12279A	Umbralisib tosylate	Inhibitor	/	Unkown
HY-12279B	Umbralisib sulfate	Inhibitor	/	Unkown
HY-15856A	Flupentixol		/	Unkown
HY-15856BR	Flupentixol dihydrochloride (Standard)		/	Unkown
HY-17457	Levalbuterol hemitartrate		98.71%	Yes
HY-B0093AR	Benazepril hydrochloride (Standard)	Inhibitor	/	Unkown
HY-B0965R	Thioridazine hydrochloride (Standard)		/	Unkown
HY-B1203R	Fludrocortisone (Standard)		/	Unkown
HY-W008923R	Doxycycline monohydrate (Standard)		/	Unkown
HY-10201AR	Sorafenib tosylate (Standard)		/	Unkown
HY-90003AR	Tianeptine sodium salt (Standard)		/	Unkown

Clinical Phase

Bioactive Molecules (82)

Cat. No.	Product Name	Effect	Purity	Phase
HY-18085A	Quercetin hydrate		98.45%	Phase 4
HY-D0803	Thymoquinone		99.80%	Phase 4
HY-102031	Linperlisib	Inhibitor	98.83%	Phase 4
HY-16441	Tegafur-gimeracil-oteracil potassium		99.96%	Phase 4
HY-14971A	AKT inhibitor IV	Inhibitor	99.40%	Phase 4
HY-18085G	Quercetin (GMP)		/	Phase 4
HY-10201S4	Sorafenib-d3 tosylate		/	Phase 4
HY-125101A	Rafutrombopag diolamine		/	Phase 4
HY-N12959	5,4'-Dihydroxy-6,8-dimethoxy-7-O-rhamnosyl flavone	Inhibitor	/	Phase 4
HY-10681	Gedatolisib	Inhibitor	99.89%	Phase 3
HY-156681	Tersolisib	Inhibitor	99.77%	Phase 3
HY-19962	Paxalisib	Inhibitor	99.51%	Phase 3
HY-153306	Zovegalisib	Inhibitor	99.70%	Phase 3
HY-13898	Taselisib	Inhibitor	99.75%	Phase 3
HY-N0104	Curcumol	Inducer	99.50%	Phase 3
HY-15174	Dactolisib Tosylate		99.87%	Phase 3
HY-12037	Rigosertib sodium		99.57%	Phase 3
HY-15180	Buparlisib Hydrochloride		99.51%	Phase 3
HY-18719	Endoxifen (Z-isomer)		99.19%	Phase 3
HY-19763	Ifupinostat		99.30%	Phase 3
HY-172581	Clifutinib		99.59%	Phase 3
HY-109068A	Parsaclisib hydrochloride	Inhibitor	99.33%	Phase 3
HY-N0728A	α-Linolenic acid sodium	Inhibitor	96.67%	Phase 3
HY-109198A	Zandelisib hydrochloride	Inhibitor	/	Phase 3
HY-50094	Pictilisib		99.80%	Phase 2
HY-100716	Eganelisib	Inhibitor	99.68%	Phase 2
HY-139609	Camonsertib	Inhibitor	99.99%	Phase 2
HY-19719	Miransertib	Inhibitor	99.32%	Phase 2
HY-13522	Fimepinostat		99.95%	Phase 2
HY-15245	GSK2636771	Inhibitor	99.88%	Phase 2
HY-15177	PF-04691502		99.33%	Phase 2
HY-N9481	Lipoteichoic acid		/	Phase 2
HY-12513	Samotolisib		98.85%	Phase 2
HY-13246	Apitolisib		99.29%	Phase 2
HY-12868	Bimiralisib	Inhibitor	98.62%	Phase 2
HY-12330	AZD8186	Inhibitor	99.98%	Phase 2
HY-16526	Pilaralisib	Inhibitor	99.14%	Phase 2
HY-10111	TG100-115	Inhibitor	99.41%	Phase 2
HY-15900	Voxtalisib	Inhibitor	99.82%	Phase 2
HY-135827	Roginolisib	Inhibitor	99.66%	Phase 2
HY-13334	BGT226 maleate		99.92%	Phase 2
HY-12948	AMG319	Inhibitor	99.09%	Phase 2
HY-N6775	Sonolisib	Inhibitor	≥99.0%	Phase 2
HY-10202	Tandutinib		99.48%	Phase 2
HY-115870	AZD8154	Inhibitor	99.88%	Phase 2
HY-P0118	Disitertide		98.03%	Phase 2
HY-17645	Tenalisib	Inhibitor	98.83%	Phase 2
HY-10220	SF1126	Inducer	/	Phase 2
HY-16754	Seletalisib	Inhibitor	99.79%	Phase 2
HY-132601	Cobomarsen	Inhibitor	/	Phase 2
HY-19535	Nemiralisib hydrochloride	Inhibitor	98.86%	Phase 2
HY-132807	Amdizalisib	Inhibitor	/	Phase 2
HY-109029	Dezapelisib	Inhibitor	/	Phase 2
HY-19535B	Nemiralisib succinate	Inhibitor	/	Phase 2
HY-N13200	Cranberry Extract		/	Phase 2
HY-10108	LY294002		99.95%	Phase 1
HY-10297	Omipalisib		99.94%	Phase 1
HY-101625	Recilisib	Activator	99.94%	Phase 1
HY-159852	BBO-10203		99.12%	Phase 1
HY-50847	ZSTK474		99.71%	Phase 1
HY-16585	VS-5584	Inhibitor	98.71%	Phase 1
HY-19896	COTI-2		99.02%	Phase 1
HY-12036	GSK1059615		99.76%	Phase 1
HY-N2037A	Higenamine hydrochloride		99.34%	Phase 1
HY-100886	BAY1082439		99.35%	Phase 1
HY-162472	XRD-0394	Inhibitor	98.54%	Phase 1
HY-15837	SAR-260301	Inhibitor	99.95%	Phase 1
HY-11080	PKI-179	Inhibitor	98.0%	Phase 1
HY-15466	Izorlisib		99.01%	Phase 1
HY-12644	Acalisib	Inhibitor	99.98%	Phase 1
HY-12869	AZD-8835	Inhibitor	98.38%	Phase 1
HY-124036	DS-7423	Inhibitor	99.83%	Phase 1
HY-15280	GSK2292767	Inhibitor	98.89%	Phase 1
HY-100694	GS-9901	Inhibitor	99.97%	Phase 1
HY-141876	PRT543		/	Phase 1
HY-15960	PWT-33597 free base		/	Phase 1
HY-101625A	Recilisib sodium	Activator	/	Phase 1
HY-162878	CHF-6523	Inhibitor	/	Phase 1
HY-106006	RV-1729	Inhibitor	/	Phase 1
HY-114214	CKD-712		/	Phase 1
HY-16769	Panulisib		/	Phase 1
HY-113402B	Gamma-glutamylcysteine ammonium		/	Phase 1

Inhibitory Antibodies (6)

Cat. No.	Product Name	Effect	Purity	Phase
HY-P99463	Batiraxcept	Inhibitor	99.91%	Phase 3
HY-P991524	MM-111	Inhibitor	/	Phase 2
HY-P99304	Lumretuzumab	Inhibitor	≥99.0%	Phase 1
HY-P990610	KHK-2898	Inhibitor	97.16%	Phase 1
HY-P991641	IMC-EB10	Inhibitor	98%	Phase 1
HY-P991984	SIBP-03	Inhibitor	/	Phase 1

Pre-clinical Phase

Bioactive Molecules (974)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-19312	3-Methyladenine	Inhibitor	99.91%	Unkown
HY-P0175	740 Y-P		99.67%	Unkown
HY-10197	Wortmannin	Inhibitor	99.86%	Unkown
HY-18234A	Leupeptin hemisulfate		98.36%	Yes
HY-12016	KU-55933	Inhibitor	99.92%	Unkown
HY-N0728	α-Linolenic acid	Inhibitor	99.92%	Unkown
HY-11006	KU-57788	Inhibitor	99.95%	Unkown
HY-12481	SAR405	Inhibitor	99.74%	Unkown
HY-70063	Buparlisib		99.90%	Unkown
HY-50673	Dactolisib		99.94%	Unkown
HY-13002	Torin 2		99.69%	Unkown
HY-N0776	Isorhamnetin	Inhibitor	99.94%	Unkown
HY-12795	Vps34-IN-1		99.79%	Unkown
HY-113402	Gamma-glutamylcysteine		98.53%	Unkown
HY-10115	PI-103		99.82%	Unkown
HY-154848	UCL-TRO-1938	Activator	99.98%	Unkown
HY-124719	hSMG-1 inhibitor 11j	Inhibitor	99.82%	Unkown
HY-D0254	Gallein		98.0%	Unkown
HY-100355	C18-Ceramide (d18:1/18:0)		99.95%	Unkown
HY-P1410B	D-GsMTx4	Inhibitor	99.44%	Unkown
HY-N0451	Acacetin	Inducer	99.71%	Unkown
HY-12341	Onvoloxastat	Inhibitor	98.11%	Unkown
HY-110171	iMDK	Inhibitor	99.35%	Unkown
HY-N0143	Phlorizin		99.93%	Unkown
HY-10108A	LY294002 hydrochloride		99.97%	Unkown
HY-N0484	Liensinine		99.97%	Unkown
HY-N0270	Ononin		99.97%	Unkown
HY-N0022	Isoacteoside		99.67%	Unkown
HY-113308A	Taurolithocholic acid sodium salt		99.81%	Unkown
HY-144806	PI3K/AKT-IN-1		99.64%	Unkown
HY-N0457	Chicoric acid	Inducer	99.86%	Unkown
HY-N0787	Cryptochlorogenic acid		99.87%	Unkown
HY-12030	PIK-90	Inhibitor	99.70%	Unkown
HY-106591A	4-Vinylcyclohexene dioxide		98.57%	Unkown
HY-151527	PI3K/Akt/CREB activator 1		98.64%	Unkown
HY-N1435	Oroxin B		99.39%	Unkown
HY-N0361	Dihydrocapsaicin		99.93%	Unkown
HY-15719	NU 7026		99.97%	Unkown
HY-N0031	Plantamajoside		99.80%	Unkown
HY-12037A	Rigosertib		99.01%	Unkown
HY-13425	Deguelin		99.20%	Unkown
HY-N0284	Esculetin	Inhibitor	99.79%	Unkown
HY-N2515	Ginsenoside Rk1		99.90%	Unkown
HY-103450	G36	Antagonist	99.35%	Unkown
HY-N0330	Momordin Ic		99.78%	Unkown
HY-13532	AS-252424	Inhibitor	99.66%	Unkown
HY-113308	Taurolithocholic acid		99.7%	Unkown
HY-N2037	Higenamine		99.31%	Unkown
HY-10114	TGX-221	Inhibitor	99.59%	Unkown
HY-12046	PIK-93	Inhibitor	99.81%	Unkown
HY-W011927	4,4'-Sulfonyldiphenol		99.81%	Unkown
HY-P1410C	D-GsMTx4 TFA	Inhibitor	99.89%	Unkown
HY-P1925A	GO-203 TFA		98.39%	Unkown
HY-131615	TPC2-A1-P	Agonist	99.79%	Unkown
HY-124760	hSMG-1 inhibitor 11e	Inhibitor	99.94%	Unkown
HY-N0076	Bilobalide	Inhibitor	99.92%	Unkown
HY-116035	Nimbolide		99.79%	Unkown
HY-N0103	Sophocarpine		99.85%	Unkown
HY-N0563	Alizarin		99.48%	Unkown
HY-N0815	Resibufogenin		99.93%	Unkown
HY-I1124	L-Valine-d8		99.91%	Unkown
HY-N0448	10-Gingerol		99.48%	Unkown
HY-N1381	Periplocin	Inducer	99.81%	Unkown
HY-N0837	Veratramine		99.88%	Unkown
HY-12794	Vps34-PIK-III	Inhibitor	99.63%	Unkown
HY-15477	YS-49		99.98%	Unkown
HY-N2026	Propylparaben		99.91%	Unkown
HY-18676	OSU-T315		99.88%	Unkown
HY-N2187	Deoxyshikonin		99.96%	Unkown
HY-13334A	BGT226		99.85%	Unkown
HY-N1346	Robinin		99.96%	Unkown
HY-N6739	Beauvericin		99.97%	Unkown
HY-18939	N6-Cyclohexyladenosine		99.98%	Unkown
HY-N0847	Micheliolide	Inhibitor	99.77%	Unkown
HY-W010201	Citronellol		98.40%	Unkown
HY-128483	Fusaric acid		99.94%	Unkown
HY-N0265	Asperosaponin VI	Inhibitor	99.62%	Unkown
HY-N0717S6	L-Valine-13C5		99.6%	Unkown
HY-P0118B	Disitertide diammonium		99.00%	Unkown
HY-N0876	Arenobufagin	Inducer	99.82%	Unkown
HY-12068	PI3K-IN-1	Inhibitor	99.93%	Unkown
HY-130413	Protectin D1		99.10%	Unkown
HY-150795	SY-LB-35		99.54%	Unkown
HY-131015	HaXS8		99.28%	Unkown
HY-N2593	Isorhapontigenin		99.82%	Unkown
HY-128574	D927	Activator	99.46%	Unkown
HY-160093	SQLE-IN-1		99.21%	Unkown
HY-168438	ERBB agonist-1		99.16%	Unkown
HY-N0819	Raddeanin A		98.68%	Unkown
HY-10109	AS-605240		99.36%	Unkown
HY-103100	SB-699551		99.53%	Unkown
HY-N0493	Pectolinarigenin		99.98%	Unkown
HY-N1255	Scoulerine		99.99%	Unkown
HY-N7204	4-Hydroxyderricin		99.79%	Unkown
HY-N0078	Ginkgolic Acid (C13:0)	Inhibitor	99.92%	Unkown
HY-15290	AIM-100	Inhibitor	99.95%	Unkown
HY-118119	CAY10526		99.12%	Unkown
HY-156406	PITCOIN4	Inhibitor	99.97%	Unkown
HY-122620	Rafutrombopag (tautomerism)		98.33%	Unkown
HY-162713	MTX-531		99.87%	Unkown
HY-100398	PF-04979064	Inhibitor	99.93%	Unkown
HY-N0721	Neoandrographolide		99.41%	Unkown
HY-N2484	Methylnissolin	Inhibitor	99.92%	Unkown
HY-10044	WYE-132		99.90%	Unkown
HY-110171A	iMDK quarterhydrate	Inhibitor	99.37%	Unkown
HY-125848	Ginsenoside F2		99.92%	Unkown
HY-12763	GNE-317	Inhibitor	98.76%	Unkown
HY-143404	PI3K-IN-30	Inhibitor	98.19%	Unkown
HY-N5112B	β,β-Dimethylacrylshikonin		99.30%	Unkown
HY-N1535	Ponicidin		99.93%	Unkown
HY-122862	RAS inhibitor Abd-7	Inhibitor	99.57%	Unkown
HY-Y1322	Triphenyl phosphate		99.67%	Unkown
HY-N0616	Trifolirhizin		99.82%	Unkown
HY-N0657	Pinoresinol Diglucoside		99.84%	Unkown
HY-P4322	H-Ile-Lys-Val-Ala-Val-OH	Activator	99.35%	Unkown
HY-109068	Parsaclisib	Inhibitor	99.75%	Unkown
HY-117163	FzM1.8	Agonist	98.93%	Unkown
HY-N0660	Jujuboside B		99.92%	Unkown
HY-P10580	Vasculotide	Activator	99.84%	Unkown
HY-10683	PKI-402	Inhibitor	99.17%	Unkown
HY-10115A	PI-103 Hydrochloride		98.06%	Unkown
HY-113402A	Gamma-glutamylcysteine TFA		96.68%	Unkown
HY-13431	KU-0060648	Inhibitor	99.87%	Unkown
HY-N0735	Phellodendrine chloride		99.68%	Unkown
HY-N2112	Glaucocalyxin A		99.88%	Unkown
HY-N2554	Osthenol		99.15%	Unkown
HY-N6263	EGCG Octaacetate	Inhibitor	98.57%	Unkown
HY-N6950	Hederacolchiside A1		98.28%	Unkown
HY-139534	ARI-1		99.16%	Unkown
HY-160099	20-5,14-HEDE		99.66%	Unkown
HY-N0712	Typhaneoside		99.74%	Unkown
HY-N0777	Isorhamnetin-3-O-glucoside		99.96%	Unkown
HY-N0885	Telocinobufagin		99.93%	Unkown
HY-N2447	Amarogentin		99.93%	Unkown
HY-N2491	Deoxyelephantopin	Inhibitor	99.87%	Unkown
HY-10110	IC-87114	Inhibitor	99.85%	Unkown
HY-128741	D-Allose		99.85%	Unkown
HY-N2110	Phellopterin		99.94%	Unkown
HY-N3312	Matairesinol	Inhibitor	98.78%	Unkown
HY-N0696	Sipeimine	Inhibitor	98.57%	Unkown
HY-106012	PI4K-IN-1	Inhibitor	98.59%	Unkown
HY-146751	PI3K/Akt/mTOR-IN-2		99.93%	Unkown
HY-N0314	Pectolinarin		99.89%	Unkown
HY-N0728S3	α-Linolenic acid-13C18	Inhibitor	99.5%	Unkown
HY-20180	Pictilisib dimethanesulfonate		99.72%	Unkown
HY-N0747	Oxypeucedanin		99.50%	Unkown
HY-N5027	Oxyberberine		99.78%	Unkown
HY-W011927S	4,4'-Sulfonyldiphenol-d8		99.21%	Unkown
HY-W015777	4-Methoxybenzyl alcohol		99.93%	Unkown
HY-109198	Zandelisib	Inhibitor	99.67%	Unkown
HY-19535A	Nemiralisib	Inhibitor	99.80%	Unkown
HY-N0726	Dracorhodin perchlorate		99.02%	Unkown
HY-N1431	Tabersonine		98.13%	Unkown
HY-101146	SF2523	Inhibitor	99.34%	Unkown
HY-12017	PF-04217903		99.85%	Unkown
HY-N0910	Notoginsenoside Ft1		99.49%	Unkown
HY-111570	PI3Kγ inhibitor AZ2	Inhibitor	99.75%	Unkown
HY-13440	AMG 511	Inhibitor	99.76%	Unkown
HY-141807	MS21	Degrader	99.64%	Unkown
HY-N0534	Vitexin-2"-O-rhamnoside		99.78%	Unkown
HY-N3354	Lupiwighteone	Inducer	98.92%	Unkown
HY-P10580A	Vasculotide TFA	Activator	99.88%	Unkown
HY-11002	CP-466722	Inhibitor	99.74%	Unkown
HY-115620	AQX-016A		99.51%	Unkown
HY-156371	MIPS-21335	Inhibitor	99.61%	Unkown
HY-D0892	NSP-DMAE-NHS		99.48%	Unkown
HY-N0392	Polygalasaponin F		99.85%	Unkown
HY-N0695	Schisantherin B		99.75%	Unkown
HY-N0717S	L-Valine-15N		99.74%	Unkown
HY-N2081	Skimmianine	Inhibitor	99.93%	Unkown
HY-N4205	Tetrahydropiperine	Inhibitor	99.41%	Unkown
HY-N5048	Galloylpaeoniflorin	Inhibitor	98.30%	Unkown
HY-N6983	Licoricesaponin G2		99.87%	Unkown
HY-10811	GNE-493	Inhibitor	99.81%	Unkown
HY-B0633D	Hyaluronic acid sodium (MW 200-1560)		99.41%	Unkown
HY-19719A	Miransertib hydrochloride	Inhibitor	99.74%	Yes
HY-111508	PI3K/mTOR Inhibitor-2	Inhibitor	99.10%	Unkown
HY-15672	FM19G11	Inhibitor	98.39%	Unkown
HY-118020A	Loliolide		99.92%	Unkown
HY-128393	Trilinolein		98.0%	Unkown
HY-14971	(E)-Akt inhibitor-IV	Inhibitor	98.63%	Unkown
HY-40029	(S)-1-Boc-3-aminopiperidine		99.95%	Unkown
HY-B1885	Fenitrothion		99.43%	Unkown
HY-N0728R	α-Linolenic acid (Standard)	Inhibitor	99.32%	Unkown
HY-N3651	Curzerenone		98.55%	Unkown
HY-N5072	Desmethylglycitein	Inhibitor	99.99%	Unkown
HY-N6002	3'-Hydroxypterostilbene	Inducer	99.89%	Unkown
HY-17044A	Duvelisib (R enantiomer)	Inhibitor	99.00%	Unkown
HY-12034	WYE-354		98.03%	Unkown
HY-173405	VVD-699	Inhibitor	99.83%	Unkown
HY-112440	HZX-02-059	Inhibitor	99.40%	Unkown
HY-131972	PF-06843195	Inhibitor	98.12%	Unkown
HY-100385	Brevianamide F	Inhibitor	99.03%	Unkown
HY-117548	UNC1062		98.92%	Unkown
HY-149669	PH14	Inhibitor	99.09%	Unkown
HY-B0633I	Hyaluronic acid sodium (MW 800kDa)		/	Unkown
HY-N0479	Licarin B	Activator	99.93%	Unkown
HY-N0717S1	L-Valine-13C5,15N		99.64%	Unkown
HY-N2132	Flavokawain B		99.99%	Unkown
HY-N3127	Orobol	Inhibitor	99.74%	Unkown
HY-N1103	Vasicine		98.80%	Unkown
HY-101272	GDC-0326	Inhibitor	99.92%	Unkown
HY-19798	PI4KIIIbeta-IN-9	Inhibitor	99.18%	Unkown
HY-101667	LTURM34	Inhibitor	99.35%	Unkown
HY-112443	AZD3458	Inhibitor	99.71%	Unkown
HY-112897	IITZ-01		98.18%	Unkown
HY-100603	GSK-F1	Inhibitor	95.06%	Unkown
HY-106263B	Tyroserleutide hydrochloride		99.92%	Unkown
HY-108016	Peruvoside		99.32%	Unkown
HY-149091	KDM5B-IN-4	Inhibitor	99.56%	Unkown
HY-15294	CZC24832	Inhibitor	99.07%	Unkown
HY-156681A	(S)-Tersolisib	Control	99.18%	Unkown
HY-16596	CNX-1351	Inhibitor	98.87%	Unkown
HY-17587	4-Methylbenzylidene camphor		99.87%	Unkown
HY-N0103A	Sophocarpine monohydrate		99.91%	Unkown
HY-N0430A	Coptisine Sulfate		99.37%	Unkown
HY-N0699	Daphnoretin		99.83%	Unkown
HY-N0902	Dihydrosanguinarine	Inhibitor	99.98%	Unkown
HY-N2787	8-Prenylnaringenin		99.63%	Unkown
HY-100470	NSC781406	Inhibitor	99.97%	Unkown
HY-107365	PQR530	Inhibitor	99.98%	Unkown
HY-18085S1	Quercetin-d3		98.73%	Unkown
HY-11095	NPS 2390		99.90%	Unkown
HY-13531	AS-604850	Inhibitor	99.32%	Unkown
HY-161615	PROTAC ATR degrader-2		99.73%	Unkown
HY-172741	Dioctanoyl PI(3,5)P2 sodium		98.7%	Unkown
HY-G0007	Omeprazole sulfone	Control	99.23%	Unkown
HY-N0670	Tenacissoside H	Inhibitor	99.89%	Unkown
HY-N2445	Flavokawain C		99.79%	Unkown
HY-P11474	FZ1 peptide		99.92%	Unkown
HY-W009141	1-Monopalmitin		99.89%	Unkown
HY-11042	GNE-477	Inhibitor	98.75%	Unkown
HY-107364	MTX-211	Inhibitor	99.81%	Unkown
HY-118712	WYE-23	Inhibitor	99.24%	Unkown
HY-121222	alpha-Bisabolol		80.0%	Unkown
HY-126066	(-)-Syringaresinol		99.93%	Unkown
HY-128333	PI3K/mTOR Inhibitor-4	Inhibitor	97.04%	Unkown
HY-132601A	Cobomarsen sodium		99.29%	Unkown
HY-163962	L18I		99.89%	Unkown
HY-165099	C-8 Ceramide-1-phosphate		99.0%	Unkown
HY-174976	FHND5032	Inhibitor	99.49%	Unkown
HY-18719A	Endoxifen (Z-isomer hydrochloride)		99.49%	Unkown
HY-N4185	Licoflavone A		99.95%	Unkown
HY-N6064	Polygalacin D		99.95%	Unkown
HY-W1126235	DS02312223	Activator	98.24%	Unkown
HY-W130965	1-Formyl-beta-carboline	Inhibitor	99.70%	Unkown
HY-136198	SRX3207	Inhibitor	98.50%	Unkown
HY-108606	PI-828	Inhibitor	99.62%	Unkown
HY-124652	TBK1/IKKε-IN-4	Inhibitor	99.42%	Unkown
HY-150618	PI3Kα-IN-9		98.78%	Unkown
HY-153894	SRX3177		99.33%	Unkown
HY-157169	IBL-302	Inhibitor	95.49%	Unkown
HY-178500A	WCY-8-67 TFA		99.40%	Unkown
HY-181420A	BBO-11818		99.77%	Unkown
HY-60298	6-Bromo-1H-indazole		99.40%	Unkown
HY-N0717S4	L-Valine-1-13C		99.75%	Unkown
HY-N3000	6-Methoxydihydrosanguinarine		99.88%	Unkown
HY-P2196A	ELA-32(human) TFA	Agonist	99.93%	Unkown
HY-W004121	4-Biphenylsulfonyl chloride		99.59%	Unkown
HY-Y1177	Diphenyl disulfide		99.96%	Unkown
HY-15643A	LY 303511 hydrochloride		98.87%	Unkown
HY-167876	PQR514		99.28%	Unkown
HY-103224	PIT-1	Inhibitor	98.08%	Unkown
HY-112613	UCB9608	Inhibitor	99.59%	Unkown
HY-151622	PI3K/mTOR Inhibitor-11	Inhibitor	99.65%	Unkown
HY-15868	HS-173		99.04%	Unkown
HY-13333	NVP-BAG956	Inhibitor	98.23%	Unkown
HY-145526	Hydroxy celecoxib	Activator	98.71%	Unkown
HY-162382	KTC1101	Inhibitor	98.09%	Unkown
HY-17508S1	Clarithromycin-d3	Inhibitor	99.90%	Unkown
HY-N0608	Myrislignan		99.53%	Unkown
HY-N0857	Deoxyandrographolide	Activator	99.80%	Unkown
HY-N1103A	Vasicine hydrochloride		98.62%	Unkown
HY-N1967	Dihydrocurcumin	Modulator	99.58%	Unkown
HY-N3011	Iridin		99.72%	Unkown
HY-N6017	Bakkenolide A		99.99%	Unkown
HY-NP192	Sericin		0%	Unkown
HY-10681R	Gedatolisib (Standard)	Inhibitor	97.70%	Unkown
HY-12235	PI-3065	Inhibitor	98.32%	Unkown
HY-15477A	YS-49 monohydrate		99.56%	Unkown
HY-10202A	Tandutinib hydrochloride		99.29%	Unkown
HY-120213	YH-306		98.34%	Unkown
HY-125847	Salvianolic acid F		99.50%	Unkown
HY-143275	HL-8	Inhibitor	99.13%	Unkown
HY-168608	TRPM7-IN-1		98.83%	Unkown
HY-176811	VVD-442	Inhibitor	99.97%	Unkown
HY-19312S	3-Methyladenine-d3		98.98%	Unkown
HY-46866	Isoegomaketone		95.04%	Unkown
HY-N0887	Isoastragaloside I		99.49%	Unkown
HY-N2045	Musk ketone		99.21%	Unkown
HY-N2590	Lupenone	Inhibitor	99.74%	Unkown
HY-N3720	Demethoxycapillarisin	Inhibitor	99.93%	Unkown
HY-N4246	Bacopaside I		99.20%	Unkown
HY-N7695	Physalin B		97.20%	Unkown
HY-NP203	High density lipoprotein (human)	Activator	98.00%	Unkown
HY-113402R	Gamma-glutamylcysteine (Standard)		98.14%	Unkown
HY-130687A	Psicose		99.90%	Unkown
HY-N0853A	Alisol A 24-acetate		98.0%	Unkown
HY-N2026S1	Propylparaben-d4		99.62%	Unkown
HY-13530	CAY10505		99.75%	Unkown
HY-136268	AQX-435	Activator	99.15%	Unkown
HY-110193	SPP-86	Inhibitor	99.87%	Unkown
HY-123952	RTC-5	Inhibitor	99.37%	Unkown
HY-12895	SKI V		98.95%	Unkown
HY-13514	TG 100713	Inhibitor	99.21%	Unkown
HY-143403	PI3K-IN-31	Inhibitor	99.33%	Unkown
HY-169212	I194496	Inhibitor	98.52%	Unkown
HY-174461	PROTAC PI3Kα degrader-1	Degrader	99.21%	Unkown
HY-180261	GP262		98.75%	Unkown
HY-N1399	Androsin		99.94%	Unkown
HY-N6841	Rhodiolin		98%	Unkown
HY-N7363	Isolongifolene	Inducer	98.0%	Unkown
HY-W127575	Cholesta-3,5-diene	Activator	99.54%	Unkown
HY-118717	mTOR inhibitor WYE-28	Inhibitor	99.75%	Unkown
HY-12017A	PF-04217903 mesylate		99.82%	Unkown
HY-126049	(S)-Oxiracetam	Inhibitor	99.56%	Unkown
HY-20176	2,4-Dichlorothieno[3,2-d]pyrimidine		/	Unkown
HY-10812	GNE-490	Inhibitor	96.79%	Unkown
HY-18650	KU 59403	Inhibitor	99.23%	Unkown
HY-11105	Pilaralisib analogue		99.74%	Unkown
HY-111383	LX2343		99.80%	Unkown
HY-111510	IPI-3063	Inhibitor	99.59%	Unkown
HY-112608	CHMFL-PI3KD-317	Inhibitor	98.04%	Unkown
HY-132231	FD223		98.05%	Unkown
HY-147419	Vulolisib	Inhibitor	99.61%	Unkown
HY-100603A	(S)-GSK-F1	Inhibitor	99.60%	Unkown
HY-10201S2	Sorafenib-13C,d3		98.35%	Unkown
HY-107207	Kaempferol 3-neohesperidoside		99.68%	Unkown
HY-131502	Taspine	Inhibitor	98.0%	Unkown
HY-133907	NVS-PI3-4	Inhibitor	99.40%	Unkown
HY-144993	PI3Kδ/γ-IN-1	Inhibitor	99.39%	Unkown
HY-15271	WYE-687	Inhibitor	98.12%	Unkown
HY-161366	OMS14	Inhibitor	99.09%	Unkown
HY-163853	Antidiabetic agent 6	Activator	99.97%	Unkown
HY-168906	BI-113823		99.23%	Unkown
HY-176812	VVD-849		99.76%	Unkown
HY-18234C	Leupeptin Ac-LL hydrochloride		95.0%	Unkown
HY-19341	Compound 401	Inhibitor	99.97%	Unkown
HY-N0143A	Phlorizin dihydrate		99.51%	Unkown
HY-N0761A	trans-Isoferulic acid		99.93%	Unkown
HY-N2000	Bellidifolin	Modulator	99.74%	Unkown
HY-N2911	Auriculasin		98.58%	Unkown
HY-N3035	Tetrahydroepiberberine	Inhibitor	99.38%	Unkown
HY-N5136	25(R,S)-Ruscogenin	Inhibitor	99.83%	Unkown
HY-N6896	Isoviolanthin	Inhibitor	99.87%	Unkown
HY-N6932	Voacamine		99.64%	Unkown
HY-N7832	Petunidin-3-O-glucoside chloride		98.11%	Unkown
HY-W005308	N-BOC-DL-serine methyl ester		98.0%	Unkown
HY-120265	MIPS-9922	Inhibitor	99.25%	Unkown
HY-122949	Momordicine I		97.0%	Unkown
HY-12340	ETP-46321	Inhibitor	99.34%	Unkown
HY-101776A	Desmethyl-VS-5584 hydrochloride	Inhibitor	98.63%	Unkown
HY-145589	Rafutrombopag		95.29%	Unkown
HY-146223	AZD4625		98.44%	Unkown
HY-101921	PI3Kδ-IN-1	Inhibitor	99.60%	Unkown
HY-131345	PI3Kα-IN-4	Inhibitor	99.76%	Unkown
HY-131345A	(S)-PI3Kα-IN-4	Inhibitor	99.77%	Unkown
HY-133124	PARP/PI3K-IN-1		99.40%	Unkown
HY-B0965AS	Thioridazine-d3 hydrochloride		98.25%	Unkown
HY-10620	PI3K-IN-22	Inhibitor	99.50%	Unkown
HY-10681S	Gedatolisib-d8		98.71%	Unkown
HY-110109	ETP-45658	Inhibitor	98.97%	Unkown
HY-11080A	PKI-179 hydrochloride	Inhibitor	99.66%	Unkown
HY-111209	Pichromene	Inhibitor	98.7%	Unkown
HY-118521	AS-041164	Inhibitor	99.02%	Unkown
HY-124535	TGX-115	Inhibitor	99.31%	Unkown
HY-124834	Nrf2 activator-10		98.65%	Unkown
HY-12652	AZD3147	Inhibitor	99.93%	Unkown
HY-130307	Rubrofusarin	Inhibitor	98.19%	Unkown
HY-137340	WH-10417-099	Degrader	98.14%	Unkown
HY-147284	PI3K-IN-37	Inhibitor	99.0%	Unkown
HY-150019	PI3K-IN-36	Inhibitor	98.76%	Unkown
HY-153120A	PI3K/mTOR Inhibitor-13 sodium	Inhibitor	98.11%	Unkown
HY-153306A	(S)-Zovegalisib	Control	99.89%	Unkown
HY-155066	FD274		99.45%	Unkown
HY-157704	18:1 PI(3)P		99%	Unkown
HY-163299	pan-KRAS-IN-5		96.70%	Unkown
HY-174798	PI3Kα Ligand-1	Ligand	98.0%	Unkown
HY-18085S	Quercetin-d5		96.72%	Unkown
HY-B0633E	Hyaluronic acid, low endotoxin		/	Unkown
HY-N0427	Phellodendrine		99.60%	Unkown
HY-N12044	Asparanin A	Inducer	/	Unkown
HY-N12124	Monascuspiloin		95%	Unkown
HY-N1904	4′-Hydroxywogonin		98.22%	Unkown
HY-N4042	Hirsutenone	Inhibitor	99.74%	Unkown
HY-N7635	Oleanolic acid 28-O-β-D-glucopyranoside		99.42%	Unkown
HY-N8884	Coelonin	Inhibitor	98.0%	Unkown
HY-P6292	KS-133		98.75%	Unkown
HY-W049881	9-Methyl-β-carboline		99.86%	Unkown
HY-W713284	2-Ethylhexyl (E)-3-(4-(methoxy-d3)phenyl)acrylate		99.87%	Unkown
HY-12338	ON 146040	Inhibitor	95.05%	Unkown
HY-155520	Antileishmanial agent-19	Inhibitor	99.45%	Unkown
HY-156872	MTX-216		/	Unkown
HY-50673A	Dactolisib hydrochloride		99.41%	Unkown
HY-N0565S1	Doxycycline-d3 (hyclate) (major)		95.10%	Unkown
HY-N0728S	α-Linolenic acid-d5	Inhibitor	99.9%	Unkown
HY-N6739S	Beauvericin-13C45	Inhibitor	≥99%	Unkown
HY-W075770	Nickel(II) oxide		≥99.0%	Unkown
HY-101517	PI3K-IN-2	Inhibitor	99.62%	Unkown
HY-135827A	Roginolisib hemifumarate	Inhibitor	99.80%	Unkown
HY-178500	WCY-8-67		/	Unkown
HY-131910	IHMT-PI3Kδ-372	Inhibitor	99.69%	Unkown
HY-101517A	(S)-PI3K-IN-2	Inhibitor	99.50%	Unkown
HY-103030	PI3K-IN-32	Inhibitor	99.7%	Unkown
HY-108418A	(R)-PI3Kδ-IN-15	Control	99.52%	Unkown
HY-109633	PI3K/mTOR-IN-23	Inhibitor	99.9%	Unkown
HY-109633A	PI3K/mTOR-IN-23 dihydrochloride	Inhibitor	99.70%	Unkown
HY-112172	Tenalisib R Enantiomer		99.63%	Unkown
HY-113308S1	Taurolithocholic acid-d4		98.36%	Unkown
HY-120438	TASP0415914	Inhibitor	99.02%	Unkown
HY-123849	SN32976	Inhibitor	99.49%	Unkown
HY-125542	DCZ3301		99.73%	Unkown
HY-132276	PtdIns-(3,4,5)-P3-biotin sodium		98.0%	Unkown
HY-13504	PIK-293	Inhibitor	99.43%	Unkown
HY-136512	Streptazolin		98.65%	Unkown
HY-13864	PF-4989216		99.38%	Unkown
HY-143883	MS143	Degrader	97.8%	Unkown
HY-147768	PI3K/AKT-IN-2		98.10%	Unkown
HY-15271A	WYE-687 dihydrochloride	Inhibitor	≥98.0%	Unkown
HY-155232	PI3Kδ-IN-16		99.02%	Unkown
HY-160550	DPM-1003		/	Unkown
HY-16122B	CAL-130 Hydrochloride	Inhibitor	98.74%	Unkown
HY-17635S	Leniolisib-d5	Inhibitor	98.78%	Unkown
HY-18085AS	Quercetin-d3 hydrate		96.44%	Unkown
HY-183068	AP4-43	Inhibitor	99.76%	Unkown
HY-203618	PI3K/mTOR ligand-1	Ligand	97.28%	Unkown
HY-B0725S	Doxepin-d3 hydrochloride		99.88%	Unkown
HY-N0430	Coptisine		/	Unkown
HY-N0451R	Acacetin (Standard)	Inducer	98.19%	Unkown
HY-N0728S2	α-Linolenic acid-d14	Inhibitor	99.9%	Unkown
HY-N10144	Shinpterocarpin	Inhibitor	/	Unkown
HY-N2051	Zeylenone	Activator	98.0%	Unkown
HY-N2199	Sotetsuflavone		96.75%	Unkown
HY-N3260	Methyllucidone		98.0%	Unkown
HY-N3542	Carpachromene	Inhibitor	98.84%	Unkown
HY-N5014	Liensinine perchlorate		99.67%	Unkown
HY-N6580	Ginsenoside Rg4		99.94%	Unkown
HY-P0118A	Disitertide TFA		/	Unkown
HY-W010201R	Citronellol (Standard)		97.16%	Unkown
HY-W040417	Boc-L-cyclobutylglycine		98.91%	Unkown
HY-Y1322S	Triphenyl phosphate-d15		99.74%	Unkown
HY-108418	PI3Kδ-IN-15	Inhibitor	99.52%	Unkown
HY-108649A	MRS2768 tetrasodium salt		98.70%	Unkown
HY-113402AR	Gamma-glutamylcysteine TFA (Standard)		95.17%	Unkown
HY-15174R	Dactolisib Tosylate (Standard)		98.95%	Unkown
HY-15872	FTI-277		/	Unkown
HY-16355	NVP-QAV-572	Inhibitor	98.53%	Unkown
HY-176422	(S,R,S)-AHPC-Amide-PEG2-C2-NH2		97.16%	Unkown
HY-N0265R	Asperosaponin VI (Standard)	Inhibitor	99.46%	Unkown
HY-N2026A	Propylparaben sodium		99.03%	Unkown
HY-N2026R	Propylparaben (Standard)		99.81%	Unkown
HY-U00326	PI3Kα/mTOR-IN-1	Inhibitor	99.30%	Unkown
HY-W010667	(Z)-2-(Oleoyloxy)propane-1,3-diyl dipalmitate		98.01%	Unkown
HY-W274807	TM-2-51		99.95%	Unkown
HY-101798	MDVN1003	Inhibitor	/	Unkown
HY-10201S1	Sorafenib-d4		99.9%	Unkown
HY-142646	PI3Kδ-IN-9	Inhibitor	/	Unkown
HY-144876	RIDR-PI-103	Inducer	98.02%	Unkown
HY-18085S2	Quercetin-13C3		/	Unkown
HY-101114	LAS191954	Inhibitor	/	Unkown
HY-112602	PI3K/mTOR Inhibitor-1	Inhibitor	/	Unkown
HY-113308AS	Taurolithocholic acid-d4 sodium		99.4%	Unkown
HY-12017B	PF-04217903 phenolsulfonate		/	Unkown
HY-128582	PI3K/HDAC-IN-1	Inhibitor	/	Unkown
HY-132880	GSK251	Inhibitor	99.88%	Unkown
HY-134472	PI3Kδ-IN-8	Inhibitor	/	Unkown
HY-151137	HSP90/mTOR-IN-1		/	Unkown
HY-18234	Leupeptin		/	Unkown
HY-18719S	Endoxifen-d5 (Z-isomer)		/	Unkown
HY-B1203S	Fludrocortisone-d5		/	Unkown
HY-N0565AS	Doxycycline-d3 (hydrochloride)		/	Unkown
HY-N0565S3	Doxycycline-13C,d3		/	Unkown
HY-100424	PI3K-IN-63	Inhibitor	/	Unkown
HY-101115	PI3K-IN-6	Inhibitor	/	Unkown
HY-112286	PI3Kγ inhibitor 2	Inhibitor	/	Unkown
HY-112439	PI3Kdelta inhibitor 1	Inhibitor	/	Unkown
HY-112614	ATM Inhibitor-1	Inhibitor	/	Unkown
HY-118903	PIK-124	Inhibitor	/	Unkown
HY-132299	PI3Kγ inhibitor 4	Inhibitor	/	Unkown
HY-133029	PI3K-IN-9	Inhibitor	/	Unkown
HY-15960A	PWT-33597		/	Unkown
HY-174366	JMC14	Inhibitor	/	Unkown
HY-184099	Zinilisib	Inhibitor	/	Unkown
HY-139521S	Doxepin-d3		/	Unkown
HY-10109A	AS-605240 potassium	Inhibitor	/	Unkown
HY-101145	CK37	Inhibitor	/	Unkown
HY-10116	PI-540	Inhibitor	/	Unkown
HY-101776	Desmethyl-VS-5584	Inhibitor	/	Unkown
HY-105666	TGX-155	Inhibitor	/	Unkown
HY-10681S1	Gedatolisib-d6	Inhibitor	/	Unkown
HY-107387	PF-376304	Inhibitor	/	Unkown
HY-108649	MRS2768		/	Unkown
HY-108958	(Rac)-AZD8186	Inhibitor	/	Unkown
HY-108959	D-87503	Inhibitor	/	Unkown
HY-111058	D-106669	Inhibitor	/	Unkown
HY-111137	Puquitinib	Inhibitor	/	Unkown
HY-111172	Inotilone	Inhibitor	95.26%	Unkown
HY-112191	PI3K-IN-10	Inhibitor	/	Unkown
HY-113308AS2	Taurolithocholic acid-d4-1 sodium		/	Unkown
HY-113308S	Taurolithocholic acid-d5		/	Unkown
HY-113572	PX-866-17OH	Inhibitor	/	Unkown
HY-113817	SHIP1 activator 1		/	Unkown
HY-114923	SU-11752	Inhibitor	/	Unkown
HY-115814	AM-1430	Inhibitor	/	Unkown
HY-116431	I-BOP	Agonist	/	Unkown
HY-116497	PH11	Inhibitor	/	Unkown
HY-116604	RLX	Inhibitor	/	Unkown
HY-116604A	RLX hydrochloride	Inhibitor	/	Unkown
HY-116882	PIK-39	Inhibitor	/	Unkown
HY-118160	PPM-18		99.17%	Unkown
HY-120037	A 80426		/	Unkown
HY-120116	AM-8508	Inhibitor	/	Unkown
HY-120135	LTURM 36	Inhibitor	/	Unkown
HY-120281	ST-168		/	Unkown
HY-121012	(rac)-AG-205		/	Unkown
HY-12279F	Umbralisib R-enantiomer	Inhibitor	99.52%	Unkown
HY-123862	LAS195319	Inhibitor	/	Unkown
HY-124615	ST-162	Antagonist	/	Unkown
HY-124647	PI3Kα-IN-1	Inhibitor	/	Unkown
HY-12482	X-370		/	Unkown
HY-125376	PI3Kδ-IN-3	Inhibitor	/	Unkown
HY-126083	17β-Hydroxywortmannin	Inhibitor	/	Unkown
HY-128027	eCF309	Inhibitor	98.2%	Unkown
HY-128393S2	Trilinolein-d5		/	Unkown
HY-128633	DHW-208		/	Unkown
HY-128634	Anticancer agent 164		/	Unkown
HY-128741S	D-Allose-13C		/	Unkown
HY-128741S1	D-Allose-13C-1		/	Unkown
HY-128741S2	D-Allose-13C-2		/	Unkown
HY-130133	DHW-221		/	Unkown
HY-131055	Mytoxin B		/	Unkown
HY-131910A	(R)-IHMT-PI3Kδ-372	Inhibitor	99.75%	Unkown
HY-132898	PI3K-IN-23	Activator	/	Unkown
HY-135526	Demethoxyviridiol	Inhibitor	/	Unkown
HY-136806	PI3K-IN-12	Inhibitor	/	Unkown
HY-13685S1	Miltefosine-d4	Inhibitor	/	Unkown
HY-138302	PF-06862309		/	Unkown
HY-139832	MCX 28	Inhibitor	/	Unkown
HY-139880	PI3Kγ inhibitor 5	Inhibitor	/	Unkown
HY-141476	PI3K/mTOR Inhibitor-3	Inhibitor	/	Unkown
HY-14152	Prucalopride hydrochloride	Agonist	/	Unkown
HY-14153S	Tegaserod-d11		/	Unkown
HY-141690A	PI3K-IN-19 hydrochloride	Inhibitor	/	Unkown
HY-142676	PI3K-IN-26	Inhibitor	/	Unkown
HY-142677	PI3K-IN-27		/	Unkown
HY-143277	HL-2		/	Unkown
HY-143472	PI3Kδ-IN-11		/	Unkown
HY-144059	AKT-IN-9	Inhibitor	/	Unkown
HY-144060	AKT-IN-10	Inhibitor	/	Unkown
HY-144224S	Tianeptine-d6 hydrochloride		/	Unkown
HY-144254	PI3Kδ-IN-10		/	Unkown
HY-144295	PI3Kα-IN-5	Inhibitor	/	Unkown
HY-144450	PI3K-IN-29	Inhibitor	/	Unkown
HY-144686	ATM Inhibitor-3	Inhibitor	/	Unkown
HY-144687	ATM Inhibitor-4	Inhibitor	/	Unkown
HY-144692	MEK/PI3K-IN-1	Inhibitor	/	Unkown
HY-144693	MEK/PI3K-IN-2	Inhibitor	/	Unkown
HY-145338	PI3Kβ-IN-1	Inhibitor	/	Unkown
HY-145358	FAP-PI3KI1	Inhibitor	/	Unkown
HY-145432	PI3K-IN-28	Inhibitor	/	Unkown
HY-146016	PI3K/mTOR Inhibitor-5	Inhibitor	/	Unkown
HY-146159	PI3K/HDAC-IN-2	Inhibitor	/	Unkown
HY-146200	PI3K/mTOR Inhibitor-8	Inhibitor	/	Unkown
HY-146223A	(3R,10R,14aS)-AZD4625		98.00%	Unkown
HY-146260	NVP-CLR457	Inhibitor	/	Unkown
HY-146504	Topoisomerase I/II inhibitor 3		/	Unkown
HY-146743	Antitumor agent-53	Inducer	/	Unkown
HY-146789	PI3Kδ/γ-IN-2	Inhibitor	/	Unkown
HY-146835S	(Rac)-16:0PI(3,5)P2-d5 ammonium		/	Unkown
HY-147285	PI3K/mTOR Inhibitor-9	Inhibitor	/	Unkown
HY-147567	ATR-IN-15	Inhibitor	/	Unkown
HY-147613	PI3K/mTOR Inhibitor-6	Inhibitor	/	Unkown
HY-147614	PI3K/mTOR Inhibitor-7	Inhibitor	/	Unkown
HY-147767	PI3Kα-IN-6		/	Unkown
HY-147792	WNY1613	Inhibitor	/	Unkown
HY-147898	PI3K-IN-33		/	Unkown
HY-147899	PI3K-IN-34		/	Unkown
HY-147900	PI3K-IN-35		/	Unkown
HY-147911	COX-2/PI3K-IN-1	Inhibitor	/	Unkown
HY-147912	COX-2/PI3K-IN-2	Inhibitor	/	Unkown
HY-147913	PI3K/Akt/mTOR-IN-3		/	Unkown
HY-147966	HDAC-IN-43	Inhibitor	/	Unkown
HY-147983	PI3Kα-IN-8		/	Unkown
HY-148317	PI3Kγ inhibitor 6	Inhibitor	/	Unkown
HY-148972	PI(3,5)P2 diC16		/	Unkown
HY-149000	PI3Kα-IN-7		/	Unkown
HY-149092	Anticancer agent 109		/	Unkown
HY-149205	CXJ-2	Inhibitor	/	Unkown
HY-149235	PI3Kδ-IN-12	Inhibitor	/	Unkown
HY-149427	PI3Kα-IN-12	Inhibitor	/	Unkown
HY-149472	Anti-osteoporosis agent-4	Inhibitor	/	Unkown
HY-149493	IHMT-PI3K-455	Inhibitor	/	Unkown
HY-149521	PI3K-IN-47	Inhibitor	/	Unkown
HY-149539	PLM-101	Inhibitor	/	Unkown
HY-149556	MTX-241F	Inhibitor	/	Unkown
HY-149634	PI3Kδ-IN-17	Inhibitor	/	Unkown
HY-150034	PI3K-IN-38	Inhibitor	/	Unkown
HY-150061	NVP-BBD130	Inhibitor	/	Unkown
HY-150587	Anti-inflammatory agent 31	Inhibitor	/	Unkown
HY-150638	PI3Kδ/γ-IN-3		/	Unkown
HY-151635	PI3K/VEGFR2-IN-1		/	Unkown
HY-151915	ATR-IN-20	Inhibitor	/	Unkown
HY-152238	PI3K/mTOR Inhibitor-12	Inhibitor	/	Unkown
HY-15244G	Alpelisib (GMP)		/	Unkown
HY-15268	PP487	Inhibitor	/	Unkown
HY-152774	Antitumor agent-86	Inhibitor	/	Unkown
HY-153120	PI3K/mTOR Inhibitor-13	Inhibitor	/	Unkown
HY-153703	PI3Kγ inhibitor 7	Inhibitor	/	Unkown
HY-153915	PI3Kα-IN-11	Inhibitor	95.35%	Unkown
HY-155124	Antiproliferative agent-32	Inducer	/	Unkown
HY-155180	FD2056	Inhibitor	/	Unkown
HY-155570	Anticancer agent 137		/	Unkown
HY-155730	PI3K-IN-41	Inhibitor	/	Unkown
HY-155833	PI3Kδ-IN-13	Inhibitor	/	Unkown
HY-155890	Fimepinostat mesylate		/	Unkown
HY-155975	PI3Kδ-IN-14	Inhibitor	/	Unkown
HY-155996	FD2157		/	Unkown
HY-156018	PI3Kα-IN-13	Inhibitor	/	Unkown
HY-156080	PI3K-IN-48	Inhibitor	/	Unkown
HY-156091	PI3Kα/HDAC6-IN-1	Inhibitor	/	Unkown
HY-15643B	LY 303511 dihydrochloride		/	Unkown
HY-156445	PI3K/mTOR Inhibitor-14	Inhibitor	/	Unkown
HY-157125	PI3Kα-IN-14		/	Unkown
HY-157128	PI3Kδ-IN-18	Inhibitor	/	Unkown
HY-157295	PI3K/HDAC-IN-3	Inhibitor	/	Unkown
HY-157319	PI3Kα-IN-15	Inhibitor	/	Unkown
HY-157648	18:0-20:4 PI(3)P ammonium		/	Unkown
HY-157652	18:0-20:4 PI(3,4,5)P3		/	Unkown
HY-157707	18:1 PI(3,4,5)P3		/	Unkown
HY-157714	08:0 PI(3,4)P2		/	Unkown
HY-158017	WXM-1-170		/	Unkown
HY-158029	PI3Kα-IN-21		/	Unkown
HY-158050	PXB17	Inhibitor	/	Unkown
HY-158147	PI3Kδ-IN-20	Inhibitor	/	Unkown
HY-158156	NF-κB-IN-16		/	Unkown
HY-158688	PI3Kδ-IN-21	Inhibitor	/	Unkown
HY-159510	VEGFR-2-IN-51		/	Unkown
HY-159517	PI3K/Akt/mTOR-IN-5		/	Unkown
HY-159577	Nic-15	Modulator	/	Unkown
HY-159892	PD-1/PD-L1-IN-54		/	Unkown
HY-160099S	20-5,14-HEDE-d2		/	Unkown
HY-160099S1	20-5,14-HEDE-d2-1		/	Unkown
HY-160099S2	20-5,14-HEDE-d2-2		/	Unkown
HY-160282	PI3K-IN-49	Inhibitor	/	Unkown
HY-160283	PI3K-IN-50	Inhibitor	/	Unkown
HY-160418	PI3K-IN-51	Inhibitor	/	Unkown
HY-160864	Torbafylline	Inhibitor	/	Unkown
HY-161140	PI3Kα-IN-16	Inhibitor	/	Unkown
HY-161144	AKT-IN-21		/	Unkown
HY-161301	PI3K-IN-52	Inhibitor	/	Unkown
HY-161362	SR-3-65		/	Unkown
HY-161373	PI3Kα-IN-22	Inhibitor	/	Unkown
HY-161816	PI3K/AKT-IN-3		/	Unkown
HY-161852	PI3K-IN-55		/	Unkown
HY-161858	EpskA21		/	Unkown
HY-161874	RPS6-IN-1		/	Unkown
HY-161968	EGFR/PI3Kα-IN-1	Inhibitor	/	Unkown
HY-162060	YPX-C-05		98.05%	Unkown
HY-162268	MALT1-IN-13		/	Unkown
HY-162292	Anticancer agent 190	Inhibitor	/	Unkown
HY-162647	PI3Kδ-IN-22	Inhibitor	/	Unkown
HY-162802	PI3K/AKT-IN-4		/	Unkown
HY-162848	IHMT-PI3K-315	Inhibitor	/	Unkown
HY-163151	JE-133	Inhibitor	/	Unkown
HY-16332	ML-220		/	Unkown
HY-163360	PI3Kα-IN-19	Inhibitor	/	Unkown
HY-163361	PI3Kα-IN-20	Inhibitor	/	Unkown
HY-163501	PI3Kα-IN-23	Inhibitor	/	Unkown
HY-163511	PI3K/Akt/mTOR-IN-4		/	Unkown
HY-163533	CPD-002	Inhibitor	/	Unkown
HY-163538	TYM-3-98		99.56%	Unkown
HY-16461	Solenopsin		/	Unkown
HY-165394	Melafolone	Inhibitor	/	Unkown
HY-168319	PI3Kγ ligand 1		/	Unkown
HY-168609	CRI9		/	Unkown
HY-168718	FAK-IN-22		/	Unkown
HY-168858	TRK-IN-30	Inhibitor	/	Unkown
HY-168893	K882		/	Unkown
HY-168919	KRASG12C IN-16		/	Unkown
HY-169019	XJTU-L453		/	Unkown
HY-169100	Antiproliferative agent-57	Inhibitor	/	Unkown
HY-169403	NW16		/	Unkown
HY-169413	AKT-IN-25	Inhibitor	/	Unkown
HY-169983	PI3Kδ-IN-23	Inhibitor	/	Unkown
HY-170648	TS-IN-5		/	Unkown
HY-170656	PI3K/mTOR-IN-24	Inhibitor	/	Unkown
HY-170877	SHP2-IN-35		/	Unkown
HY-170912	Topo I/II-IN-2		/	Unkown
HY-171558	PI3K-IN-56	Inhibitor	/	Unkown
HY-171777	Erufosine	Inhibitor	/	Unkown
HY-172130	PI3Kδ/BET-IN-1	Inhibitor	/	Unkown
HY-172139	PI3Kα-IN-25	Inhibitor	/	Unkown
HY-172175	HYS-072		/	Unkown
HY-172201	NF-κB-IN-19		/	Unkown
HY-172255	PI4KIII beta inhibitor 4		/	Unkown
HY-172256	PI4KIII beta inhibitor 5	Inhibitor	/	Unkown
HY-172259	Toyaburgine	Inhibitor	/	Unkown
HY-172620	LIB3S0280		99.89%	Unkown
HY-172771	Multi-target kinase inhibitor 4	Inhibitor	/	Unkown
HY-172784	Anticancer agent 273		/	Unkown
HY-172785	PI3K-IN-57	Inhibitor	/	Unkown
HY-172886	PI3K-IN-58		/	Unkown
HY-172889	PI3K/HDAC-IN-4		/	Unkown
HY-172892	PI3K-IN-59	Inhibitor	/	Unkown
HY-172964	KIM-161		/	Unkown
HY-173005	JZ19	Inhibitor	/	Unkown
HY-173007	ALK/PI3K/AKT-IN-1		/	Unkown
HY-173165	OA-Br-1		/	Unkown
HY-173367	Anticancer agent 271	Inhibitor	/	Unkown
HY-173368	Antiproliferative agent-67	Inhibitor	/	Unkown
HY-173437	CW-2	Degrader	/	Unkown
HY-173493	ALK-IN-31		/	Unkown
HY-174306	MARY1		/	Unkown
HY-174321	A2073	Inhibitor	/	Unkown
HY-174324	VEGFR-2/P-gp-IN-1		/	Unkown
HY-174379	KRAS IN-44		/	Unkown
HY-174396	PI3Kδ/HDAC6-IN-1		/	Unkown
HY-174469	PROTAC PI3K/110β degrader-2		/	Unkown
HY-174855	PI3K/mTOR-IN-17		/	Unkown
HY-175002	PI3Kδ-IN-24		/	Unkown
HY-175068	D-myo-Inositol-1,3,4,5,6-pentaphosphate sodium		/	Unkown
HY-175317	Nogo-B-IN-1		/	Unkown
HY-175369	PI3Kδ-IN-25	Inhibitor	/	Unkown
HY-175734	PI3Kδ-IN-26	Inhibitor	/	Unkown
HY-175874	Tubulin-IN-55		/	Unkown
HY-176239	PROTAC PI3Kδ degrader-1		/	Unkown
HY-176281	PI3Kα-IN-26	Inhibitor	/	Unkown
HY-176421	PROTAC PI3K/110β degrader-1	Degrader	/	Unkown
HY-17651	PI3K-IN-60	Inhibitor	/	Unkown
HY-176854	PI3K/mTOR-IN-18	Inhibitor	/	Unkown
HY-177149	Allantoin ascorbate		/	Unkown
HY-177270	CHNQD-01281	Modulator	/	Unkown
HY-177277	HM5023507	Inhibitor	/	Unkown
HY-177277A	(R)-HM5023507	Inhibitor	/	Unkown
HY-177762	Pan-RAS-IN-8	Inhibitor	/	Unkown
HY-177908	SH-273		/	Unkown
HY-178304S	L-Valine-d7		/	Unkown
HY-178305S	L-Valine-d		/	Unkown
HY-178371	PI3KC2γ-IN-1	Inhibitor	/	Unkown
HY-178485	SJY26	Inhibitor	/	Unkown
HY-178812	PI3Kα-IN-27		/	Unkown
HY-178955	EGFR-IN-182		/	Unkown
HY-178984	PI3Kα-IN-28		/	Unkown
HY-178993	PI3K/AKT-IN-5		/	Unkown
HY-178996	FLT3-IN-36		/	Unkown
HY-179032	VEGFR-2-IN-77		/	Unkown
HY-179155	PI3K/mTOR-IN-19		/	Unkown
HY-179424	PROTAC HIF-1α degrader-2		/	Unkown
HY-179457	CC-11	Inhibitor	/	Unkown
HY-179464	CC-M-1	Inhibitor	/	Unkown
HY-179498	ROCK2-IN-13		/	Unkown
HY-179623	PI3Kα-IN-29		/	Unkown
HY-180112	SH543		/	Unkown
HY-180192	Dehydroxy-oridonin-vinyl ester		/	Unkown
HY-180281	PLAGL2-IN-1		/	Unkown
HY-180556	PI3K/mTOR-IN-20	Inhibitor	/	Unkown
HY-180853	PI3K/Akt/mTOR-IN-6		/	Unkown
HY-181015	α-D-Manp(3→1)-α-D-Manp(2→1)-α-D-Glu		/	Unkown
HY-181093	EGFR-IN-191		/	Unkown
HY-181097	EGFR-IN-192		/	Unkown
HY-181099	EGFR WT/T790M-IN-4		/	Unkown
HY-181150	Hit20	Inhibitor	/	Unkown
HY-181153	PROTAC FGFR3 Degrader-1	Degrader	/	Unkown
HY-181420	(S,R,S)-BBO-11818		/	Unkown
HY-181479	EGFR-IN-196		/	Unkown
HY-181581	IMM-H012	Inhibitor	/	Unkown
HY-181670	WH23		/	Unkown
HY-181710	LASSBio-2337	Inhibitor	/	Unkown
HY-181741	PI3K-001		/	Unkown
HY-181801	FASN-IN-8		/	Unkown
HY-181833	PI3K/PIKK-IN-1	Inhibitor	/	Unkown
HY-181855	PI3K/PIKK-IN-2	Inhibitor	/	Unkown
HY-181883	KRAS-IN-55	Inhibitor	/	Unkown
HY-182003	Anticancer agent 308		/	Unkown
HY-182066	Photosensitizer-9	Activator	/	Unkown
HY-182083	PROTAC PI3Kα/δ degrader-1	Degrader	/	Unkown
HY-182086	Copanlisib-NH	Ligand	/	Unkown
HY-182236	JRN73958		/	Unkown
HY-182282	PI3K/AKT-IN-6	Inhibitor	/	Unkown
HY-18234B	Leupeptin Ac-LL		/	Unkown
HY-182368	PI3Kα-IN-30		/	Unkown
HY-182614	BJ-2302	Inhibitor	/	Unkown
HY-182671	SRX3305		/	Unkown
HY-182693	CPL302-253	Inhibitor	/	Unkown
HY-182946	PI3Kα-IN-31	Inhibitor	/	Unkown
HY-183069	FKL-137		/	Unkown
HY-183272	PI3K/Akt/mTOR-IN-7	Inhibitor	/	Unkown
HY-183285	PI3Kα-IN-32	Inhibitor	/	Unkown
HY-183316	Anticancer agent 319		/	Unkown
HY-183327	PI3K/mTOR-IN-22	Inhibitor	/	Unkown
HY-183741	VVD-844	Inhibitor	/	Unkown
HY-183770	LCI40	Inhibitor	/	Unkown
HY-183787	PI3Kα-IN-33		/	Unkown
HY-183922	SRX3212	Inhibitor	/	Unkown
HY-184001	LT-1339-553	Inhibitor	/	Unkown
HY-184119	Pabgraminone C		/	Unkown
HY-184125	PI3Kδ-IN-28	Inhibitor	/	Unkown
HY-184167	COH-19		/	Unkown
HY-184303	Antihypertensive agent 7	Activator	/	Unkown
HY-184311	EGFR-IN-214		/	Unkown
HY-184321	LC-MG-5		/	Unkown
HY-184322	LC-MG-10		/	Unkown
HY-184385	PI3K/AKT/JAK2-IN-1	Inhibitor	/	Unkown
HY-184412	SDUY104		/	Unkown
HY-184422	SOS1-IN-26		/	Unkown
HY-184423	SOS1-IN-27		/	Unkown
HY-184487	Anticancer agent 331		/	Unkown
HY-184574	HDAC-IN-104		/	Unkown
HY-184703	Antidiabetic agent 9	Activator	/	Unkown
HY-185205	VVD-484	Inhibitor	/	Unkown
HY-185460	Pertuzumab-LD3	Inhibitor	/	Unkown
HY-187155	Cyclo(Gly-{Tyr(PO3H2)}-Val-Pro-Met-Leu)		/	Unkown
HY-187454	PI3Kα/CDK7-IN-1		/	Unkown
HY-19719B	Miransertib mesylate	Inhibitor	/	Unkown
HY-48869	PI3K-IN-46		98.0%	Unkown
HY-B0093AS	Benazepril-d5 hydrochloride	Inhibitor	/	Unkown
HY-B1203S1	Fludrocortisone-d2		/	Unkown
HY-B1550S	Benzoin-d10	Inhibitor	/	Unkown
HY-B1885S	Fenitrothion-d6		/	Unkown
HY-E70609	PIK3CG Recombinant Human Active Lipid Kinase		/	Unkown
HY-E70631	PIP5K1A Recombinant Human Active Lipid Kinase		/	Unkown
HY-E70789	BCR-RET Recombinant Human Active Protein Kinase		/	Unkown
HY-E70855	PKCζ Recombinant Human Active Protein Kinase		/	Unkown
HY-G0007S	Omeprazole sulfone-d3	Control	/	Unkown
HY-G0007S1	Omeprazole sulfone-13C,d3	Control	/	Unkown
HY-N0361S	Dihydrocapsaicin-d3		/	Unkown
HY-N0392R	Polygalasaponin F (Standard)	Inhibitor	/	Unkown
HY-N0448A	(±)-10-Gingerol		/	Unkown
HY-N0448R	10-Gingerol (Standard)		/	Unkown
HY-N0479S	Licarin B-d4		/	Unkown
HY-N0565AG	Doxycycline (hydrochloride) (GMP)		/	Unkown
HY-N0608S	Myrislignan-13C,d2		/	Unkown
HY-N0660R	Jujuboside B (Standard)		/	Unkown
HY-N0717S2	L-Valine-13C5,15N,d8		99.3%	Unkown
HY-N0717S3	L-Valine-13C5,15N,d2		/	Unkown
HY-N0717S5	L-Valine-2-13C		/	Unkown
HY-N0717S8	L-Valine-d1		98.0%	Unkown
HY-N0717S9	L-Valine-15N,d8		/	Unkown
HY-N0776R	Isorhamnetin (Standard)	Inhibitor	/	Unkown
HY-N10106	Dihydromyristicin	Inhibitor	/	Unkown
HY-N10342	Cajanol		/	Unkown
HY-N10802	6-O-Isobutyrylbritannilactone	Inhibitor	98.34%	Unkown
HY-N12489	Ishophloroglucin A		/	Unkown
HY-N1255A	Scoulerine hydrochloride		/	Unkown
HY-N13063	Anticancer agent 235		/	Unkown
HY-N1338	Royleanone	Inhibitor	/	Unkown
HY-N15902	BODIPY 505/515 TMR PI(3,4,5)P3 ammonium		/	Unkown
HY-N15977	18:1-6:0 Biotin PI(3,5)P2 ammonium）		/	Unkown
HY-N16118	Asperosaponin V	Modulator	/	Unkown
HY-N18161	Isopsoralidin	Inhibitor	/	Unkown
HY-N19029	Vernodalin		/	Unkown
HY-N19103	3-(2-Hydroxypropyl)-8-hydroxy-3,4-dihydroisocoumarin		/	Unkown
HY-N2026AR	Propylparaben sodium (Standard)		/	Unkown
HY-N2026S	Propylparaben-d7		/	Unkown
HY-N20708	Chiisanogenin		/	Unkown
HY-N2942	Bisdemethoxycurcumin		/	Unkown
HY-N3000A	6-Methoxydihydrosanguinarine hydrochloride		/	Unkown
HY-N8931	Monomethyl lithospermate	Activator	/	Unkown
HY-N9602	6,7,4'-Trihydroxyflavanone		/	Unkown
HY-N9980	Antcin K	Inhibitor	/	Unkown
HY-P0175A	740 Y-P TFA		/	Unkown
HY-P10093	Penetratin-PI3Kγ(126-150)	Inhibitor	/	Unkown
HY-P10320	T3 Peptide	Activator	/	Unkown
HY-P10833	C-VGB3		/	Unkown
HY-P10981	ErbB2 peptide	Ligand	/	Unkown
HY-P10992	YVPGP		/	Unkown
HY-P11130	LQEQ-19 (mouse, rat)	Activator	/	Unkown
HY-P11313	Catestatin (rat)		/	Unkown
HY-P4790	Acetyl-Exenatide	Inhibitor	/	Unkown
HY-RS10463	PI3 Human Pre-designed siRNA Set A	Pre-designed Set	/	Unkown
HY-W009141S	1-Monopalmitin-d31		/	Unkown
HY-W010201S1	Citronellol-d3		/	Unkown
HY-W711035	Picolinafen		/	Unkown
HY-W714183	Dinitramine		/	Unkown
HY-W753806	Doxazosin hydrochloride	Inhibitor	/	Unkown
HY-W783478	Calebin A	Inhibitor	98.0%	Unkown
HY-W934539	Lenalidomide-amide-C8-Br		/	Unkown
HY-W940885	Pomalidomide-NH-C13-OH		/	Unkown
HY-100603B	(R)-GSK-F1	Inhibitor	/	Unkown
HY-10202B	Tandutinib sulfate		/	Unkown
HY-10549	PI3Kγ inhibitor 1	Inhibitor	/	Unkown
HY-105854A	Pipoxolan		/	Unkown
HY-107207R	Kaempferol 3-neohesperidoside (Standard)		/	Unkown
HY-107216A	(3aS,4R,9bR)-G-1		/	Unkown
HY-110038	FTI-277 TFA		/	Unkown
HY-113308AS1	Taurolithocholic Acid-d5 sodium salt		/	Unkown
HY-114457	Phosphatidylinositol 4,5-bisphosphate	Substrate	/	Unkown
HY-114894	2C07	Inhibitor	/	Unkown
HY-116191	WJD008	Inhibitor	/	Unkown
HY-116563	PI3Kα-IN-24	Inhibitor	/	Unkown
HY-117885	PF-5177624	Inhibitor	/	Unkown
HY-117923	PF-06465603	Inhibitor	/	Unkown
HY-118236	(S)-AZD 6482		/	Unkown
HY-118374	AM-9635	Inhibitor	/	Unkown
HY-12017C	PF-04217903 phosphate		/	Unkown
HY-120471	AM-0687	Inhibitor	/	Unkown
HY-121672	PI3K-IN-7		/	Unkown
HY-121684	Ramentaceone		/	Unkown
HY-123790	AS2541019	Inhibitor	/	Unkown
HY-12491	PIK-C98		/	Unkown
HY-12517	GNE-293	Inhibitor	/	Unkown
HY-128393S1	Trilinolein-13C54		/	Unkown
HY-136700	SB-699551 free base		/	Unkown
HY-136765	PI3K-IN-11	Inhibitor	/	Unkown
HY-148965A	PtdIns-(3)-P1 (1,2-dipalmitoyl) ammonium		/	Unkown
HY-150309	PI3K-IN-54	Inhibitor	98.01%	Unkown
HY-15288	PI3kδ inhibitor 1	Inhibitor	/	Unkown
HY-15466A	Izorlisib methanesulfonate		/	Unkown
HY-155211	mTOR inhibitor-13	Inhibitor	/	Unkown
HY-15643	LY 303511		/	Unkown
HY-156484	SPR519	Inhibitor	/	Unkown
HY-156487	CNBDA	Inhibitor	/	Unkown
HY-157287	(S)-Phe-A110/B319		/	Unkown
HY-157288	(R)-Phe-A110/B319		/	Unkown
HY-157649	18:0-20:4 PI (3,5) P2 triammonium		/	Unkown
HY-157685	06:0 PI(3,5)P2 ammonium		/	Unkown
HY-157706	PI(3,4)P2 (18:1) ammonium salt	Activator	/	Unkown
HY-157713	diC8PI(3,5)P2 triammonium		/	Unkown
HY-160458	PI3Kα-IN-17	Inhibitor	/	Unkown
HY-16122	CAL-130 Racemate	Inhibitor	/	Unkown
HY-16122A	CAL-130	Inhibitor	/	Unkown
HY-162023	mTOR inhibitor-10	Inhibitor	/	Unkown
HY-162024	mTOR inhibitor-16	Inhibitor	/	Unkown
HY-162025	mTOR inhibitor-17	Inhibitor	/	Unkown
HY-164384	DFX117		/	Unkown
HY-164548	WK88-1		/	Unkown
HY-164662	mTOR inhibitor-24	Inhibitor	/	Unkown
HY-167952	mTOR inhibitor-25		/	Unkown
HY-172742	Dioctanoyl PI(3,4)P2 sodium		/	Unkown
HY-174645	Human IL10RA mRNA		/	Unkown
HY-175083	PtdIns-(4,5)-P2-biotin trisodium	Substrate	/	Unkown
HY-175086	PtdIns-(3,4,5)-P3-fluorescein triethylammonium		/	Unkown
HY-175089	PtdIns-(3,4,5)-P3 (1,2-dioctanoyl) sodium		/	Unkown
HY-175407	18:0-20:4 PI(3,4,5)P3 sodium		/	Unkown
HY-175862	ALR2-IN-9		/	Unkown
HY-176832	PtdIns-(3,4)-P2 (1,2-dipalmitoyl) sodium		/	Unkown
HY-178445	PI3Kδ-IN-27	Inhibitor	/	Unkown
HY-178775	PI4K-IN-3	Inhibitor	/	Unkown
HY-179554	PtdIns-(4,5)-P2-fluorescein triethylammonium		/	Unkown
HY-181963	ZINC-1000507824		/	Unkown
HY-183405	CD2019	Agonist	/	Unkown
HY-183478	Leupeptin hydrochloride		/	Unkown
HY-185185	S58 aptamer		/	Unkown
HY-185456	PI3K/mTOR-IN-21	Inhibitor	/	Unkown
HY-185457	BrAC-GGFG-Aminal-PI3K/mTOR-IN-21	Inhibitor	/	Unkown
HY-18719H	Endoxifen (Z-isomer methanesulfonate)		/	Unkown
HY-90003S	Tianeptine-d12		/	Unkown
HY-B0725B	(Z)-Doxepin		/	Unkown
HY-B0965S	Thioridazine 2-Sulfone-d3		/	Unkown
HY-B1234S	Octinoxate-13C,d3		/	Unkown
HY-N0143R	Phlorizin (Standard)		/	Unkown
HY-N0493R	Pectolinarigenin (Standard)		/	Unkown
HY-N0565D	Doxycycline fosfatex		/	Unkown
HY-N0699R	Daphnoretin (Standard)		/	Unkown
HY-N0717S7	L-Valine-1-13C,15N		/	Unkown
HY-N0819R	Raddeanin A (Standard)	Inducer	/	Unkown
HY-N10133	Licoflavanone		/	Unkown
HY-N12531	Molephantin		/	Unkown
HY-N13164	Polygalacin D3		/	Unkown
HY-N1431A	Tabersonine hydrochloride		98.55%	Unkown
HY-N2037AS1	Higenamine-d4-1 hydrochloride		/	Unkown
HY-N20733	Bruceoside B	Inhibitor	/	Unkown
HY-N4189	Isocucurbitacin B		98.98%	Unkown
HY-N6926	1,3,5-Tricaffeoylquinic acid		/	Unkown
HY-N8380	(-)-Latifolin		/	Unkown
HY-N9164	Hecubine		/	Unkown
HY-P10393	ERα17p	Inducer	/	Unkown
HY-W010201S	Citronellol-d6	Activator	/	Unkown
HY-W636234	GSK2636771 methyl	Inhibitor	/	Unkown
HY-W714214	Ethalfluralin		/	Unkown
HY-W937057	(S,R,S)-AHPC-Me-10-bromodecanoic acid		/	Unkown
HY-Y1177R	Diphenyl disulfide (Standard)		/	Unkown
HY-122593	PI3Kδ-IN-5	Inhibitor	99.62%	Unkown
HY-18310	NIBR-17	Inhibitor	98.00%	Unkown

Inhibitory Antibodies (6)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-P991220	AL002	Agonist	98.01%	Unkown
HY-P991842	Anti-CD3 Antibody (UCHT-1)		97.26%	Unkown
HY-P990248	Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1)	Inhibitor	/	Unkown
HY-P991234	COVA208		/	Unkown
HY-P992200	Anti-CD146 Antibody (AA98)		/	Unkown
HY-P992401	M802		/	Unkown